290 related articles for article (PubMed ID: 20678804)
1. Perifoveal müller cell depletion in a case of macular telangiectasia type 2.
Powner MB; Gillies MC; Tretiach M; Scott A; Guymer RH; Hageman GS; Fruttiger M
Ophthalmology; 2010 Dec; 117(12):2407-16. PubMed ID: 20678804
[TBL] [Abstract][Full Text] [Related]
2. Loss of Müller's cells and photoreceptors in macular telangiectasia type 2.
Powner MB; Gillies MC; Zhu M; Vevis K; Hunyor AP; Fruttiger M
Ophthalmology; 2013 Nov; 120(11):2344-52. PubMed ID: 23769334
[TBL] [Abstract][Full Text] [Related]
3. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
4. Retinal crystals in type 2 idiopathic macular telangiectasia.
Sallo FB; Leung I; Chung M; Wolf-Schnurrbusch UE; Dubra A; Williams DR; Clemons T; Pauleikhoff D; Bird AC; Peto T;
Ophthalmology; 2011 Dec; 118(12):2461-7. PubMed ID: 21839520
[TBL] [Abstract][Full Text] [Related]
5. Comparison of macular pigment in three types of macular telangiectasia.
Sawa M; Gomi F; Ueno C; Suzuki M; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):689-96. PubMed ID: 22790309
[TBL] [Abstract][Full Text] [Related]
6. Glial cells of the human fovea.
Delaunay K; Khamsy L; Kowalczuk L; Moulin A; Nicolas M; Zografos L; Lassiaz P; Behar-Cohen F
Mol Vis; 2020; 26():235-245. PubMed ID: 32280188
[TBL] [Abstract][Full Text] [Related]
7. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
[TBL] [Abstract][Full Text] [Related]
8. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
[TBL] [Abstract][Full Text] [Related]
9. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
11. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
12. ASSOCIATION BETWEEN CHANGES IN MACULAR VASCULATURE IN OPTICAL COHERENCE TOMOGRAPHY- AND FLUORESCEIN- ANGIOGRAPHY AND DISTRIBUTION OF MACULAR PIGMENT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Zeimer M; Gutfleisch M; Heimes B; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2015 Nov; 35(11):2307-16. PubMed ID: 26465618
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
14. The preproliferative stage in type 2 macular telangiectasia (MacTel type 2).
Venkatesh R; Reddy NG; Mishra P; Pereira A; Mutalik D; Agrawal S; Bhatt A; Yadav NK; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):121-132. PubMed ID: 34410484
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics, multimodality imaging and treatment of macular telangiectasia type 2].
Cai Y; Shi X; Zhao MW; Li XX
Zhonghua Yan Ke Za Zhi; 2019 Jan; 55(1):68-73. PubMed ID: 30641677
[TBL] [Abstract][Full Text] [Related]
16. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
17. Fibrocontractive Müller cell phenotypes in proliferative diabetic retinopathy.
Guidry C; King JL; Mason JO
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1929-39. PubMed ID: 19117921
[TBL] [Abstract][Full Text] [Related]
18. MACULAR PIGMENT DISTRIBUTION RESPONSES TO HIGH-DOSE ZEAXANTHIN SUPPLEMENTATION IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2.
Choi RY; Gorusupudi A; Wegner K; Sharifzadeh M; Gellermann W; Bernstein PS
Retina; 2017 Dec; 37(12):2238-2247. PubMed ID: 28079755
[TBL] [Abstract][Full Text] [Related]
19. CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Leung I; Sallo FB; Bonelli R; Clemons TE; Pauleikhoff D; Chew EY; Bird AC; Peto T;
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S43-S50. PubMed ID: 29095354
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
